Elastin-like recombinamers with acquired functionalities for gene-delivery applications

Journal of Biomedical Materials Research. Part a
Maria Jesus PinaChandra P Sharma

Abstract

In this work, well-defined elastin-like recombinamers (ELRs) were studied as a choice to the existing nonviral vectors due to their biocompatibility and ease of scale-up. Functional motifs, namely penetratin and LAEL fusogenic peptides were incorporated into a basic ELR sequence, and imidazole groups were subsequently covalently bound obtaining ELRs with new functionalities. Stable polyplexes composed of plasmid DNA and ELRs were formed. A particle size around 200 nm and a zeta potential up to nearly +24 mV made them suitable for gene delivery purposes. Additionally, viability and transfection assays with C6 rat glioma cell line showed an increase in the cellular uptake and transfection levels for the construction containing the LAEL motif. This study highlights the importance of controlling the polymer functionality using recombinant techniques and establishes the utility of ELRs as biocompatible nonviral systems for gene-therapy applications.

References

Jun 27, 1997·Biochemical and Biophysical Research Communications·N OhmoriH Aoyagi
Nov 13, 1998·Journal of Pharmaceutical Sciences·R NivenJ G Smith
Feb 4, 1999·Gene Therapy·O ZelphatiP L Felgner
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·D OupickýL W Seymour
Dec 7, 2000·Critical Reviews in Therapeutic Drug Carrier Systems·S BlauA Rubinstein
Feb 21, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Haeshin LeeTae Gwan Park
Jul 10, 2003·Biochemical and Biophysical Research Communications·Per E G ThorénBengt Nordén
Sep 16, 2003·Journal of Cell Science·Susan HauptYgal Haupt
Nov 16, 2004·The Journal of Gene Medicine·Akin AkincRobert Langer
Feb 3, 2005·Nature Reviews. Molecular Cell Biology·Christine Le Roy, Jeffrey L Wrana
Feb 22, 2005·Advanced Drug Delivery Reviews·Bhawna GuptaVladimir P Torchilin
Jun 1, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·S Moein MoghimiAdam Szewczyk
Mar 21, 2007·Biomaterials·Sathya SrinivasachariTheresa M Reineke
Sep 1, 2007·Pharmaceutical Research·Tze-Haw Howard ChenDarin Y Furgeson
Dec 5, 2008·Chemical Reviews·Meredith A Mintzer, Eric E Simanek
Mar 25, 2009·British Journal of Pharmacology·Frederic HeitzGilles Divita
May 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lauren E MaysJames M Wilson
Sep 8, 2009·Journal of the Royal Society, Interface·Christopher L Grigsby, Kam W Leong
Oct 17, 2009·The AAPS Journal·Mohammed S Al-Dosari, Xiang Gao
Nov 17, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Paulo C BessaMargarida Casal
Mar 17, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Gaurav SahayAlexander V Kabanov
Mar 25, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Kohei TaharaYoshiaki Kawashima
May 19, 2010·Advanced Drug Delivery Reviews·Gene L Bidwell, Drazen Raucher
Jul 29, 2010·Molecular Cancer Research : MCR·James M Angelastro, Michael W Lamé
Dec 25, 2010·Nanomedicine·J Carlos Rodríguez-CabelloMatilde Alonso
Mar 15, 2011·International Journal of Pharmaceutics·Susan M AlexChandra P Sharma
Mar 15, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Biraja C DashAbhay Pandit
Jul 2, 2011·Nanomedicine·Jesse V JokerstSanjiv S Gambhir
Sep 8, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marianna HöselHildegard Büning
Oct 11, 2011·International Journal of Pharmaceutics·Tze-Haw H ChenGlen S Kwon
Nov 2, 2011·Methods in Molecular Biology·José Carlos Rodríguez-CabelloFrancisco Javier Arias
Jan 29, 2013·The Journal of Gene Medicine·Samantha L GinnJo Wixon
May 15, 2013·FEBS Letters·Chérine Bechara, Sandrine Sagan
May 31, 2013·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Sabrina Höbel, Achim Aigner
Jul 31, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Ulrich LächeltErnst Wagner

❮ Previous
Next ❯

Citations

Dec 26, 2015·Advanced Drug Delivery Reviews·José Carlos Rodriguez-CabelloAlessandra Girotti
May 23, 2015·Bioconjugate Chemistry·José Carlos Rodríguez-CabelloFrancisco Javier Arias
Jun 13, 2018·International Journal of Molecular Sciences·Kelsey DeFratesXiao Hu
Jul 10, 2019·Matrix Biology : Journal of the International Society for Matrix Biology·Arturo Ibáñez-FonsecaJosé Carlos Rodríguez-Cabello
Dec 4, 2019·Cancer Letters·Maria J PiñaF Javier Arias
Nov 25, 2020·Pharmaceutics·Alessandra GirottiFrancisco Javier Arias
Oct 21, 2020·Advanced Drug Delivery Reviews·Laura ChambreDavid L Kaplan
Jul 8, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Reza MohammadinejadAli Zarrabi
Apr 3, 2020·Molecular Pharmaceutics·Juan Gonzalez-ValdiviesoF Javier Arias
Apr 5, 2019·Biomacromolecules·Juan Gonzalez-ValdiviesoF Javier Arias

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.